Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Maureen Hennessey, PhD, CPCC, CPHQ

Dominic Galante, MD, MS

Cynthia Miller, MD, MPH, FACP

Jorge Font, MPH

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways

Pharma Insights

Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond

04/22/2021

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Andrew Cournoyer, RPh, MBA

The continued rise in health care spending continues to have a profound effect on the US economy and health care payers. The three complex drivers contributing to these increases include hospital, outpatient, and...

The...

04/22/2021

Journal of Clinical Pathways

Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic

02/22/2021

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...

Health...

02/22/2021

Journal of Clinical Pathways